Management of lymphangioleiomyomatosis

Management of lymphangioleiomyomatosis

Item
http://www.wikidata.org/entity/Q28084725
Is mTOR Inhibitor Good Enough for Treatment All Tumors in TSC Patients?Women with TSC: Relationship between Clinical, Lung Function and Radiological Features in a Genotyped Population Investigated for Lymphangioleiomyomatosis.Somatic overgrowth disorders of the PI3K/AKT/mTOR pathway & therapeutic strategies.Successful treatment of a patient with chyluria due to lymphangioleiomyomatosis using sirolimus.Effect of beta-agonists on LAM progression and treatment.Long-Term Effect of Sirolimus on Serum Vascular Endothelial Growth Factor D Levels in Patients With Lymphangioleiomyomatosis.Sirolimus Therapy for Patients With Lymphangioleiomyomatosis Leads to Loss of Chylous Ascites and Circulating LAM Cells.Intracrine Regulation of Estrogen and Other Sex Steroid Levels in Endometrium and Non-gynecological Tissues; Pathology, Physiology, and Drug Discovery
P2860

Management of lymphangioleiomyomatosis

Item
http://www.wikidata.org/entity/Q28084725
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Management of lymphangioleiomyomatosis
@ast
Management of lymphangioleiomyomatosis
@en
Management of lymphangioleiomyomatosis
@nl
type
label
Management of lymphangioleiomyomatosis
@ast
Management of lymphangioleiomyomatosis
@en
Management of lymphangioleiomyomatosis
@nl
prefLabel
Management of lymphangioleiomyomatosis
@ast
Management of lymphangioleiomyomatosis
@en
Management of lymphangioleiomyomatosis
@nl
P1433
P1476
P2093
P2860
P304
P31
P3181
P356
P407
P478
P50
P577
P698
P932
P3181
P356
P1433
P1476
Management of lymphangioleiomyomatosis
@en
P2093
P2860
P304
P31
P3181
P356
P407
P478
P50
P577
P698
P932